Antifibrillatory actions of cisatracurium: An atrial specific M2 receptor antagonist

Journal of Cardiovascular Electrophysiology

Volumn 19, Issue 8, 2008, Pages 861-868

  Patterson, Eugene ^a,b   Scherlag, Benjamin J ^a   Zhou, Jing ^a   Jackman, Warren M ^a   Lazzara, Ralph ^a   Coscia, Daniel ^a   Po, Sunny ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b Cardiac Arrhythmia Research Institute   (United States)

Author keywords

Arrhythmia; Atrial fibrillation; Cardiac electrophysiology; Parasympathetic nervous system; Pulmonary veins

Indexed keywords

ACETYLCHOLINE; ATROPINE; CISATRACURIUM; MUSCARINIC M2 RECEPTOR;

ACTION POTENTIAL; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; ATRIOVENTRICULAR CONDUCTION; AUTONOMIC NERVE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SPECIFICITY; EVENT RELATED POTENTIAL; EXPERIMENTAL DOG; GANGLION; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM; HEART ATRIUM FIBRILLATION; IN VITRO STUDY; MALE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; PULMONARY VEIN; RECEPTOR BLOCKING; SINUS NODE; SINUS RHYTHM; STATISTICAL SIGNIFICANCE; VAGUS NERVE STIMULATION;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRACURIUM; ATRIAL FIBRILLATION; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART ATRIA; HEART RATE; INJECTIONS, INTRAVENOUS; MALE; NEUROMUSCULAR BLOCKING AGENTS; RECEPTOR, MUSCARINIC M2;

EID: 47749138938     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2008.01123.x     Document Type: Article

References (24)

1. Coumel P : Autonomic influences in atrial tachyarrhythmias. J Cardiovasc Electrophysiol 1996 7 : 999 1007.
2. Kannel WB, Wolf PA, Benjamin EJ, Levy D : Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates. Am J Cardiol 1998 82 : 2N 9N.
3. Szekeres L, Papp G : The effect of vagal stimulation and acetylcholine on the susceptibility to fibrillation of the mammalian heart at different body temperatures. Acta Physiol Acad Sci Hung 1965 26 : 277 286.
4. Schauerte PN, Scherlag BJ, Patterson E, Scherlag MA, Matsudaira K, Nakagawa H, Jackman WM, Lazzara R : The induction of focal atrial fibrillation by cardiac autonomic nerve stimulation in the pulmonary veins and superior vena cava. J Cardiovasc Electrophysiol 2001 12 : 592 599.
5. Scherlag BJ, Patterson E, Po SS : The neural basis of atrial fibrillation. J Electrocardiol 2006 39 : S180 S183.
6. Patterson E, Po SS, Scherlag BJ, Lazzara R : Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm 2005 2 : 624 631.
7. 2+ transient: A trigger for arrhythmia formation in tissues with an abbreviated action potential. J Am Coll Cardiol 2006 47 : 1196 1206.
8. Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G, Mazzone P, Tortoriello V, Landoni G, Zangrillo A, Lang C, Tomita T, Mesa C, Mastella E, Alfieri O : Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004 109 : 327 334.
9. Scherlag BJ, Yamanashi WS, Nakagawa H, Patterson E, Po S, Jackman WM, Lazzara R : Electrical stimulation to identify neural elements on the heart. J Interven Cardiac Electrophysiol 2005 13 : 37 42.
10. Dobrzynski H, Marples DDR, Musa H, Yamanushi TT, Henderson Z, Takagishi Y, Honjo H, Kodama I, Boyett MR : Distribution of the muscarinic K+ channel proteins Kir 3.1 and Kir 3.4 in the ventricle, atrium, and sinoatrial node of the heart. J Histochem Cyto Chem 2001 49 : 1221 1234.
11. Eglen RM : Muscarinic receptor subtype pharmacology and physiology. Prog Med Chem 2005 43 : 105 136.
12. Haissaguerre M, Sanders P, Hocini M, Hsu L-F, Shah D, Scavee C, Takahashi Y, Rotter M, Paquie J-L, Garrigue S, Clemetry J, Jais P : Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome. Circulation 2004 109 : 3007 3013.
13. Patterson E, Yu X, Huang S, Garrett M, Kem DC : Suppression of autonomic-mediated triggered firing in pulmonary vein preparations, 24 hrs post coronary artery ligation in the dog. J Cardiovasc Electrophysiol 2006 17 : 763 770.
14. Harvey RD, Belevych AE : Muscarinic regulation of cardiac ion channels. Br J Pharmacol 2003 6 : 1074 1084.
15. Stengel PW, Gomeza J, Wess J, Cohen ML : M2 and M4 receptor knockout mice: Muscarinic receptor function in cardiac and smooth muscle in vitro. J Pharmacol Exp Ther 2000 292 : 877 885.
16. Shi H, Wang H, Wang Z : Identification and characterization of multiple subtypes of muscarinic acetylcholine receptors. Mol Pharmacol 1999 55 : 497 507.
17. Shi H, Yang B, Xu D, Wang H, Wang Z : Electrophysiologic characterization of cardiac muscarinic receptors. Cell Physiol Biochem 2003 13 : 59 74.
18. Stengel PW, Yamada M, Weiss J, Cohen ML : M3-receptor knockout mice: Muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea. Am J Physiol 2002 282 : R1443 1449.
19. Wang Z, Shi H, Wang H : Functional M3 muscarinic acetylcholine receptors to mammalian hearts. Br J Pharmacol 2004 142 : 395 408.
20. Jakubik J, Bacakova L, El-Fakahany EE, Tucek S : Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors. Mol Pharmacol 1997 52 : 173 179.
21. Jakubik J, Bacakova L, Lis V, El-Fakahany EE, Tucek S : Activation of muscarinic acetylcholine receptors via their allosteric sites. Proc Natl Acad Sci USA 1996 93 : 8705 8709.
22. Bryson HM, Fields D : Cisatracurium besilate. A review of its pharmacology and clinical potential in anaesthetic practice. Drugs 1997 53 : 848 866.
23. Jooste E, Klafter I, Hirschman CA, Emala CW : A mechanism for rapacuronium-induced bronchospasm: M2 receptor antagonism. Anesthesiol 2003 98 : 906 911.
24. Muslikova J, Starshinova LA, Sheikovnikov SA, Tucek S : Interaction of the neuromuscular blocking drug atracurium with muscarinic acetylcholine receptors. Physiol Res 1991 40 : 293 304.